Letters Role of comparative efficacy

Drug approvals and size of prescribing pool

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6141 (Published 27 September 2011) Cite this as: BMJ 2011;343:d6141
  1. Garrett Igoe, general practitioner1
  1. 1Virginia Primary Care, Virginia, Republic of Ireland
  1. garrett.igoe{at}hse.ie

As a GP with some conscience about the cost to the taxpayer of my prescribing decisions, I found it heartening to read Sorenson and colleagues’ article about the need to measure “comparative efficacy” for European drug approvals.1

In …

View Full Text

Log in

Log in through your institution


* For online subscription